New: The Miami Skin Spa app is here Download for rewards, easy booking & exclusive offers
September Specials are here Free bonus treatments with every package — book before September 30
← Back to journal
skincare · October 6, 2026 · 6 min read

Skin Boosters vs PDRN vs Exosomes: What's the Difference?

A skin booster is an injectable. PDRN and exosomes are serums applied during microneedling. Here is what each one is, what the studies actually show, and how we decide which fits your skin.

Skin Boosters vs PDRN vs Exosomes: What's the Difference?

Image · Miami Skin Spa, Brickell

"Skin booster," PDRN and exosomes get grouped together online, but they are three different things. A skin booster is an injectable, usually hyaluronic acid, placed into the skin in tiny droplets; SkinVive is the FDA-approved one. PDRN and exosomes are topical serums applied to the skin during or after microneedling. Different products, different routes, different evidence.

This guide covers what each one is, what the research shows, and how our providers decide which one fits.

Toskani polynucleotide serums used with microneedling at Miami Skin Spa in Brickell

What Is a Skin Booster?

"Skin booster" is an umbrella term, not a specific product. A 2024 overview in Archives of Plastic Surgery uses it for injectables made of various biological materials, most often hyaluronic acid, placed into the skin to improve hydration, elasticity and dullness rather than to add volume. In Korea and Europe the category includes products like Profhilo and Restylane Skinboosters. Those are used abroad and are not FDA-approved in the US.

SkinVive: the FDA-approved skin booster

SkinVive by Juvéderm is a hyaluronic acid gel with lidocaine, injected as microdroplets into the skin of the cheeks. The FDA approved it in May 2023 to improve skin smoothness of the cheeks in adults over 21, and in June 2026 added neck lines to the label.

The numbers behind that approval come from a randomized trial of 202 adults: at one month, 57.9% of treated participants had measurably smoother cheeks, against 4.5% of the untreated group. At six months, 55.6% still met that mark, which is why the patient label says the improvement lasts about six months for most people. The trial was run by the manufacturer, and results vary from person to person.

It is an injection, so expect injection-day effects. In the same study, redness, swelling, bruising and small bumps were common after the first treatment, and most settled within a week. A few participants had bumps that took much longer to resolve.

SkinVive is the one we reach for when the goal is smoother, more hydrated-looking cheek skin. Our skin booster injections in Miami start at $750 per treatment; see the pricing page for current numbers.

What Is PDRN?

PDRN (polydeoxyribonucleotide) and its longer-chain cousin, polynucleotides, are purified DNA fragments, usually from salmon or trout. This is the ingredient behind the "salmon DNA facial" that took off in Korean aesthetics, where a 2024 survey found 88% of dermatologists offer polynucleotide injections.

Those injections are the version in most viral videos, and none of them is FDA-approved in the US. What we offer is the topical version: a professional polynucleotide serum applied to the skin during or after SkinPen or Morpheus8. The microneedling does the main work; the serum is an optional extra on freshly treated skin.

The evidence for that topical use is early. Two small randomized split-face trials applied polynucleotides after RF microneedling: one found faster improvement in eye-area wrinkles at two months, the other found no added benefit for melasma. We go through every study in our PDRN and polynucleotides evidence review.

What Are Exosomes?

Exosomes are tiny vesicles that cells release to carry signals to other cells. In skincare they are used as a topical product, and depending on the brand they come from human cells or from plants. As with PDRN, there are no FDA-approved exosome products, so any exosome treatment in the US is a cosmetic topical, not a drug.

The research is growing fast and still uneven. A 2026 meta-analysis of 39 human studies found facial wrinkles improved by about 20% on average across trials, while noting that protocols varied widely. An overview of 17 systematic reviews was blunter about the quality of that evidence. The best single study is a split-face trial of 25 patients where an exosome product applied after fractional laser improved acne-scar scores more than laser alone, with less redness afterward. The newest RF-microneedling trial had six patients.

Here, exosomes are an add-on applied during or after SkinPen or Morpheus8. With Morpheus8 the add-on is $300; see the pricing page.

Side by Side

SkinVive
PDRN serum
Exosome serum
What it is
Hyaluronic acid gel, injected
Salmon-derived DNA fragments, topical
Cell-derived vesicles, topical
How it's used
Microdroplet injections in the cheeks or neck
Applied during or after SkinPen or Morpheus8
Applied during or after SkinPen or Morpheus8
FDA status
Approved for cheek smoothness and neck lines, adults over 21
No FDA-approved PDRN product
No FDA-approved exosome product
Chosen for
Smoother, hydrated-looking cheek skin
An optional extra to a microneedling session
An optional extra to a microneedling session
Evidence
Manufacturer-run randomized trial, 202 people
Two small split-face trials, mixed results
Small trials plus a 2026 meta-analysis of mixed quality
Downtime
Redness, swelling, bumps; most settle within a week
Follows the microneedling treatment
Follows the microneedling treatment

PDRN vs Exosomes: Which Is Better?

No human study has compared them head to head. The only direct comparison we could find was in hamsters, with injected products, which tells you nothing about a serum on your face. Both have small, early studies as topicals after microneedling, so the honest answer is that they are two different add-ons to the same base treatment, and your provider picks based on your skin, your goals and any allergies. Anyone with a fish or seafood allergy should tell us before a PDRN serum is used.

Can You Combine Them?

Yes, in a plan. SkinVive is its own appointment. PDRN or exosome serums ride along with a SkinPen or Morpheus8 session, so many patients do both over a year: SkinVive for cheek smoothness and hydration, a microneedling series for texture and fine lines, with a serum added to the microneedling if it makes sense for their skin. Your provider sets the order and spacing at your skin consultation.

Frequently Asked Questions

Is SkinVive a skin booster?

Yes, in the way the term is used. It is a hyaluronic acid injectable placed into the skin for smoothness rather than volume, and it is the only skin booster with FDA approval in the US.

How long does a skin booster like SkinVive last?

In the approval trial, most treated people still had smoother cheeks at six months. The label describes the improvement as lasting about six months for the majority of participants. Individual results vary.

Is PDRN the same as an exosome?

No. PDRN is a DNA fragment, usually from salmon. Exosomes are vesicles released by cells. Some skincare products contain both, which is where the confusion starts, but they are different ingredients with separate research.

Do PDRN or exosome serums work without microneedling?

The clinical studies on both applied them right after a procedure, on skin that had just been treated. At-home "PDRN" or exosome skincare is a different product category with different concentrations, and we would not expect the same results from it.

Which One Fits You?

If your cheeks look dull or crepey and you want a single injectable with an FDA-approved track record, start with a SkinVive consultation. If texture, fine lines or acne scarring is the concern, SkinPen or Morpheus8 is the base treatment, and the PDRN or exosome serum is a conversation to have in the treatment room. Either way, book a skin consultation at our Brickell office and we will map the plan to your face, not to a trend.

skincaremicroneedling